BIOLASE Inc. [NASDAQ:BIOL] shares were trading -0.60% to $0.30 on Thursday. Comparativley, The S&P 500 is trading at 0.5%. For the year, the stock is trading -46.12% and the five-day change stands at 7.01%.
BIOL’s next earning date is 11/04/2020. Currently, the company is booking earnings per share of -0.69.
The company is also reporting -0.69 earnings per share.
The Bears are coming
Holding a Market Cap of $27.34 million, BIOLASE Inc. has seen a trading range over the last year of $0.21-$1.07.
For the last five days, BIOL is up from its last closing price. The average shares trading hands each day is 6.35M, with average 10-day volume coming in at 1.22 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for BIOL. When we apply the Elder Force Index to BIOLASE Inc., we are seeing an Elder Force Indicator number of 0.0.
The company’s enterprise value has gone from $35.50M to $19.83M quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, BIOL made a profit of 0.94 million. BIOLASE Inc. also saw quarter revenue growth year over year of -18.10%. In addition, the company has operating cash flow of -$15.46 million.
Looking at popular technical indicators, the company’s 5-day moving average is 0.2897 compared to the 50-day moving average of 0.3009. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. BIOL currently holds a 9-day RSI of 53.21%, while 100-day RSI stands at 45.85%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. BIOL’s 9-day MACD is 0.0084 and the company’s 100-day MACD stands at -0.1118.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 27.02% by insiders and 37.78% by institutions.
Over the last six months, insiders have sold 1,770,312 with the most recent transaction from FEINBERG LARRY N, 10% Owner, with a sell at price 0.55 per share.
Overall, the recommended rating for BIOL is Strong Buy. Currently, the company has 2 analysts watching the stock, and the average quarterly earnings estimate is -0.06. Quarterly revenue estimates are averaging 5.56M with the high estimate reaching 6.1M and the low at 5.19M.